Alexandre Belot Selected Research

Hereditary Autoinflammatory Diseases

1/2021	Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.
1/2020	Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandre Belot Research Topics

Disease

13	COVID-19 06/2022 - 01/2020
8	Inflammation (Inflammations) 01/2022 - 01/2016
7	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2021 - 03/2012
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 07/2009
5	COVID-19 related pediatric multisystem inflammatory disease 06/2022 - 01/2021
5	Fever (Fevers) 09/2021 - 06/2015
5	Familial Mediterranean Fever (Periodic Disease) 01/2021 - 01/2018
5	Autoimmune Diseases (Autoimmune Disease) 12/2020 - 07/2009
4	Infections 12/2021 - 06/2015
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2020 - 04/2015
3	Bites and Stings (Sting) 01/2022 - 09/2016
3	Vasculitis (Vasculitides) 01/2022 - 05/2020
3	Pneumonia (Pneumonitis) 01/2022 - 10/2020
3	Cytokine Release Syndrome 01/2021 - 01/2018
3	Hypersensitivity (Allergy) 10/2020 - 01/2018
3	Arthritis (Polyarthritis) 01/2020 - 05/2010
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2020 - 06/2015
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022 - 01/2021
2	Critical Illness (Critically Ill) 10/2021 - 01/2021
2	Uveitis 09/2021 - 01/2018
2	Abdominal Pain (Pain, Abdominal) 01/2021 - 05/2010
2	Hereditary Autoinflammatory Diseases 01/2021 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2020
2	Mevalonate Kinase Deficiency 01/2021 - 01/2020
2	Microscopic Polyangiitis 10/2020 - 04/2015
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 10/2020 - 04/2015
2	Rheumatic Diseases (Rheumatism) 01/2019 - 04/2015
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2018 - 01/2018
2	Dermatomyositis (Dermatopolymyositis) 01/2017 - 06/2015
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2016 - 06/2015
2	Arthralgia (Joint Pain) 06/2015 - 05/2010
2	Neoplasms (Cancer) 06/2015 - 01/2013
2	Hereditary Complement Deficiency Diseases 08/2012 - 02/2012
1	Takayasu Arteritis (Arteritis, Takayasu's) 11/2022
1	Pain (Aches) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	False Aneurysm (Pseudoaneurysm) 01/2022
1	Hemorrhage 01/2022
1	Lupus Nephritis 01/2022
1	Cytopenia 12/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 12/2021
1	Enterocolitis 09/2021
1	Vasoplegia 09/2021
1	Post-Acute COVID-19 Syndrome 09/2021
1	Fatigue 09/2021
1	Asymptomatic Infections 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2021
1	Disease Progression 01/2021
1	autosomal dominant familial Periodic fever 01/2021

Drug/Important Bio-Agent (IBA)

12	AutoantibodiesIBA 01/2022 - 01/2016
8	Interferon Type IIBA 01/2022 - 01/2017
8	InterferonsIBA 01/2022 - 08/2012
8	CytokinesIBA 09/2021 - 01/2013
6	Biological ProductsIBA 09/2021 - 01/2019
5	Interleukin-1 (Interleukin 1)IBA 01/2022 - 03/2012
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 03/2012
4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 01/2020
4	InterleukinsIBA 01/2022 - 01/2020
4	AntibodiesIBA 01/2021 - 01/2019
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2021
3	C-Reactive ProteinIBA 01/2021 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 07/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
3	InflammasomesIBA 11/2019 - 01/2018
3	PyrinIBA 11/2019 - 01/2018
3	Methotrexate (Mexate)FDA LinkGeneric 05/2019 - 06/2017
2	tocilizumab (atlizumab)FDA Link 11/2022 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 09/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2020
2	VaccinesIBA 01/2022 - 06/2017
2	Antiviral Agents (Antivirals)IBA 10/2021 - 12/2020
2	Colchicine FDA LinkGeneric 01/2021 - 01/2021
2	canakinumab FDA Link 01/2021 - 01/2020
2	SteroidsIBA 01/2021 - 01/2018
2	Peptides (Polypeptides)IBA 01/2021 - 12/2015
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2019
2	Rituximab (Mabthera)FDA Link 10/2020 - 05/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2020 - 01/2020
2	AutoantigensIBA 10/2019 - 05/2016
2	Pharmaceutical PreparationsIBA 01/2019 - 06/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2013 - 07/2009
1	mRNA VaccinesIBA 06/2022
1	A 17 (A-17)IBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021
1	Ferritins (Ferritin)IBA 12/2021
1	Antirheumatic Agents (DMARD)IBA 12/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021
1	Interleukin-18 (Interleukin 18)IBA 09/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021
1	Protein Kinase CIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021

Therapy/Procedure

8	Therapeutics 09/2021 - 12/2013
2	Remission Induction 10/2020 - 05/2020
1	Laparotomy 01/2022
1	Operative Surgical Procedures 09/2021
1	Length of Stay 01/2021